THORAX
Scope & Guideline
Elevating respiratory research to new heights.
Introduction
Aims and Scopes
- Respiratory Diseases Research:
The journal publishes studies that explore various respiratory diseases including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, and lung cancer, emphasizing their pathophysiology, clinical management, and treatment outcomes. - Innovative Diagnostic Techniques:
A focus on the development and validation of new diagnostic tools and imaging techniques, including the use of artificial intelligence, molecular diagnostics, and advanced imaging methodologies to enhance the accuracy of respiratory disease diagnosis. - Public Health and Respiratory Epidemiology:
Research on the epidemiology of respiratory diseases, their risk factors, and the impact of public health interventions, with a particular emphasis on vulnerable populations and health disparities. - Clinical Trials and Therapeutics:
The journal features results from clinical trials assessing new therapies and treatment strategies for respiratory conditions, including biologic therapies, pharmacological interventions, and rehabilitation programs. - Environmental and Occupational Lung Health:
Studies examining the effects of environmental exposures, occupational hazards, and lifestyle factors on lung health, highlighting the importance of addressing these issues in public health initiatives. - Patient-Centered Research:
Research focusing on patient experiences, preferences, and outcomes in respiratory care, aiming to improve patient engagement and adherence to treatment protocols.
Trending and Emerging
- Telemedicine and Digital Health:
The rise of telehealth and digital interventions, especially in the context of the COVID-19 pandemic, has led to an increase in studies exploring their effectiveness in managing respiratory diseases. - Long COVID and Post-Acute Sequelae:
Research focusing on the long-term effects of COVID-19 on lung health and the broader implications for respiratory function is rapidly increasing, addressing a critical need in post-pandemic care. - Personalized Medicine and Genomics:
There is a notable trend towards personalized medicine, with studies exploring genetic predispositions and targeted therapies for respiratory diseases, particularly in asthma and interstitial lung disease. - Environmental Impact on Respiratory Health:
Research examining the relationship between environmental factors, such as air pollution and climate change, and their impact on lung health is gaining prominence, highlighting the need for public health interventions. - Patient-Reported Outcomes and Quality of Life:
An increasing emphasis on patient-reported outcomes and quality of life measures in clinical research underscores the importance of patient perspectives in the management of respiratory diseases.
Declining or Waning
- Traditional Pharmacological Approaches:
There is a noticeable decrease in studies centered on traditional pharmacological treatments for respiratory diseases, likely due to the growing interest in biologics and personalized medicine. - Single Disease Focus Research:
Research that exclusively targets single respiratory conditions without considering comorbidities or the broader context of respiratory health appears to be less frequent, indicating a shift towards more integrative approaches. - Basic Science Studies:
A reduction in basic science research related to lung physiology and pathophysiology may be observed, as the journal focuses more on clinical applications and translational research. - Static Diagnostic Protocols:
There is a waning interest in static diagnostic protocols that do not incorporate advanced imaging or molecular techniques, reflecting a trend towards more dynamic and multifaceted diagnostic approaches.
Similar Journals
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Innovating the future of respiratory physiology.AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.
Tuberculosis and Respiratory Diseases
Exploring the frontiers of respiratory disease management.Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.
Respiratory Medicine and Research
Advancing knowledge in pulmonary health.Respiratory Medicine and Research, published by Elsevier, is a pivotal journal in the field of Pulmonary and Respiratory Medicine, dedicated to advancing the understanding and treatment of respiratory diseases. Since its inception in 2019, the journal has provided a platform for high-quality research, contributing significantly to the scientific community's knowledge base, as reflected in its impressive Q2 categorization in 2023. With a Scopus rank of #94 out of 155, placing it in the 39th percentile, this journal is essential for researchers, professionals, and students seeking the latest advancements in respiratory medicine. Although currently categorized as a non-open access publication, it remains accessible to those affiliated with institutions with subscriptions. Published in France, the journal aims to foster collaboration and innovation by highlighting original research, clinical studies, and comprehensive reviews that address pressing issues in respiratory health.
Lung India
Pioneering the future of respiratory research.Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.
RESPIRATORY MEDICINE
Pioneering Research for Better BreathingRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
BMC Pulmonary Medicine
Empowering innovation in pulmonary medicine for a healthier tomorrow.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.
Jornal Brasileiro de Pneumologia
Empowering professionals through vital pulmonary research.Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.
EUROPEAN RESPIRATORY JOURNAL
Pioneering Research for Better BreathingThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.
Annals of the American Thoracic Society
Exploring new frontiers in pulmonary health and clinical excellence.Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.
LUNG
Advancing knowledge in pulmonary health since 1959.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.